Impivaara O, Iisalo E
Eur J Clin Pharmacol. 1985;27(6):627-32. doi: 10.1007/BF00547039.
As part of health examination of a representative sample of an adult population (n = 8000) serum digoxin concentration was measured in 661 patients on continuous digoxin therapy. The prescribed mean daily dose of digoxin was significantly higher in men (223 micrograms) than in women (201 micrograms); the dose significantly decreased with increasing age. The mean serum digoxin concentration was the same in men and women and it differed insignificantly between age groups, although older persons tended to have a higher concentration. The age - adjusted mean steady state digoxin concentration was 1.02 ng/ml in men and 0.98 ng/ml in women; in about 60% the concentration was within the "therapeutic" range (0.80-2.00 ng/ml). The concentrations were clearly related to daily dose of digoxin. At equal dose levels old persons tended to have higher concentrations than younger persons. The interindividual variation in serum digoxin concentrations was very wide. However, when digoxin measurements in the same subjects were repeated about three months later, a good correlation between the two measurements was found. The interval between the last dose of digoxin and the collection of blood (up to 41 h) had relatively little effect on individual serum digoxin concentrations. Patients on concomitant thiazide or loop diuretic therapy had the same mean serum digoxin concentration as those not-receiving a diuretic. The mean concentration was significantly higher in patients taking a thiazide or loop diuretic combined with triamterene. The difference may have been due to an interaction between triamterene and digoxin.
作为对成年人群代表性样本(n = 8000)进行健康检查的一部分,对661名持续接受地高辛治疗的患者测定了血清地高辛浓度。男性地高辛的规定平均日剂量(223微克)显著高于女性(201微克);剂量随年龄增长而显著降低。男性和女性的平均血清地高辛浓度相同,不同年龄组之间差异不显著,尽管老年人的浓度往往较高。年龄校正后的男性地高辛平均稳态浓度为1.02纳克/毫升,女性为0.98纳克/毫升;约60%的浓度在“治疗”范围内(0.80 - 2.00纳克/毫升)。浓度与地高辛的日剂量明显相关。在相同剂量水平下,老年人的浓度往往高于年轻人。血清地高辛浓度的个体间差异非常大。然而,大约三个月后对同一受试者重复进行地高辛测量时,发现两次测量之间有良好的相关性。地高辛最后一剂与采血之间的间隔时间(最长41小时)对个体血清地高辛浓度的影响相对较小。接受噻嗪类或襻利尿剂联合治疗的患者的平均血清地高辛浓度与未接受利尿剂治疗的患者相同。服用噻嗪类或襻利尿剂联合氨苯蝶啶的患者的平均浓度显著更高。这种差异可能是由于氨苯蝶啶与地高辛之间的相互作用所致。